Cargando…

Editorial: Calcium signaling in cancer immunity

Detalles Bibliográficos
Autores principales:	Amantini, Consuelo, Morelli, Maria Beatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643154/ https://www.ncbi.nlm.nih.gov/pubmed/38022525 http://dx.doi.org/10.3389/fimmu.2023.1315490

Ejemplares similares

Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune Responses
por: Santoni, Giorgio, et al.
Publicado: (2020)

Mechanosensation and Mechanotransduction in Natural Killer Cells
por: Santoni, Giorgio, et al.
Publicado: (2021)

Transient Receptor Potential (TRP) Channels: Markers and Therapeutic Targets for Cancer?
por: Morelli, Maria Beatrice, et al.
Publicado: (2022)

The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses
por: Santoni, Giorgio, et al.
Publicado: (2013)

“Immuno-Transient Receptor Potential Ion Channels”: The Role in Monocyte- and Macrophage-Mediated Inflammatory Responses
por: Santoni, Giorgio, et al.
Publicado: (2018)

Pathophysiological Role of Transient Receptor Potential Mucolipin Channel 1 in Calcium-Mediated Stress-Induced Neurodegenerative Diseases
por: Santoni, Giorgio, et al.
Publicado: (2020)

Calcium influx, oxidative stress, and apoptosis induced by TRPV1 in chronic myeloid leukemia cells: Synergistic effects with imatinib
por: Maggi, Federica, et al.
Publicado: (2023)

Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons
por: Santoni, Giorgio, et al.
Publicado: (2015)

Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients
por: Santoni, Giorgio, et al.
Publicado: (2022)

Urinary Markers in Bladder Cancer: An Update
por: Santoni, Giorgio, et al.
Publicado: (2018)

Editorial: Hippo Signaling in the Immune System
por: Chen, Lanfen, et al.
Publicado: (2020)

The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity
por: Amantini, Consuelo, et al.
Publicado: (2017)

Editorial: Adaptor Protein Regulation in Immune Signalling
por: Verma, Navin Kumar, et al.
Publicado: (2020)

Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner
por: Amantini, Consuelo, et al.
Publicado: (2016)

Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient’s Survival
por: Morelli, Maria Beatrice, et al.
Publicado: (2019)

The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment
por: Santoni, Giorgio, et al.
Publicado: (2022)

Editorial: Wnt Signaling in Immune Cell Regulation During Microbial Infection and Cancer
por: Blumenthal, Antje, et al.
Publicado: (2020)

Editorial: Danger Signals Triggering Immune Response and Inflammation
por: Ramadan, Abdulraouf, et al.
Publicado: (2017)

Editorial: The Role of Biomembranes and Biophysics in Immune Cell Signaling
por: Shi, Yan, et al.
Publicado: (2021)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses
por: Quintana, Francisco J., et al.
Publicado: (2022)

Editorial: Signaling pathways behind immune evasion and therapy resistance
por: Martin-Orozco, Elena, et al.
Publicado: (2022)

Editorial: Regulatory T lymphocytes in cancer immunity
por: Adeegbe, Dennis, et al.
Publicado: (2022)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer
por: Shetty, Shishir, et al.
Publicado: (2021)

Editorial: Immune Cell Lineage Reprogramming in Cancer
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Editorial: Deciphering the Microbiome-Immunity-Cancer Axis
por: Chen, Xin, et al.
Publicado: (2022)

Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022)

TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients
por: Morelli, Maria Beatrice, et al.
Publicado: (2022)

Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond
por: Domblides, Charlotte, et al.
Publicado: (2023)

Exploring treatment with Ribociclib alone or in sequence/combination with Everolimus in ER(+)HER2(−)Rb wild-type and knock-down in breast cancer cell lines
por: Marinelli, Oliviero, et al.
Publicado: (2020)

Editorial: Stress and Immunity
por: Bae, Yong-Soo, et al.
Publicado: (2019)

Editorial: Fibrinolysis in Immunity
por: Kolev, Krasimir, et al.
Publicado: (2020)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Editorial: Interferons: key modulators of the immune system in cancer
por: Yusuf, Nabiha, et al.
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Stromal and immune microenvironment in breast cancer metastasis
por: Lu, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1v16om8t2fsqhpo43tc5oqncq8